Michael Guger

Linz, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry.

The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry.

Journal: Journal of neurology

Published: March 14, 2026

Dissecting definitions of disability accrual in relapsing multiple sclerosis-Have we reached standardization yet?

Dissecting definitions of disability accrual in relapsing multiple sclerosis-Have we reached standardization yet?

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: December 06, 2025

Toward Brain-Computer Interface motor rehabilitation for people with Multiple Sclerosis.

Toward Brain-Computer Interface motor rehabilitation for people with Multiple Sclerosis.

Journal: Frontiers in medicine

Published: July 08, 2025

Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR).

Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR).

Journal: Journal of neurology

Published: July 04, 2025

De-Escalation Treatment Strategies From Natalizumab in Patients With Relapsing Multiple Sclerosis in Austria.

De-Escalation Treatment Strategies From Natalizumab in Patients With Relapsing Multiple Sclerosis in Austria.

Journal: European journal of neurology

Published: April 14, 2025

Cost-effectiveness of the Floodlight® MS app in Austria. Unlocking the mystery of costs and outcomes of a digital health application for patients with multiple sclerosis.

Cost-effectiveness of the Floodlight® MS app in Austria. Unlocking the mystery of costs and outcomes of a digital health application for patients with multiple sclerosis.

Journal: Digital health

Published: June 26, 2024

Early intensive versus escalation treatment in patients with relapsing-remitting multiple sclerosis in Austria.

Early intensive versus escalation treatment in patients with relapsing-remitting multiple sclerosis in Austria.

Journal: Journal of neurology

Published: January 22, 2024

Sex impacts treatment decisions in multiple sclerosis.

Sex impacts treatment decisions in multiple sclerosis.

Journal: Journal of neurology

Published: October 24, 2023

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR).

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR).

Journal: Journal of neurology

Published: June 05, 2023

Effects of horizontal versus vertical switching of disease-modifying treatment after platform drugs on disease activity in patients with relapsing-remitting multiple sclerosis in Austria.

Effects of horizontal versus vertical switching of disease-modifying treatment after platform drugs on disease activity in patients with relapsing-remitting multiple sclerosis in Austria.

Journal: Journal of neurology

Published: January 24, 2023

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR).

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR).

Journal: Journal of neurology

Published: November 29, 2022

Non-interventional, prospective, observational study on spasticity-associated symptom control with nabiximols as add-on therapy in patients with multiple sclerosis spasticity in Austria.

Non-interventional, prospective, observational study on spasticity-associated symptom control with nabiximols as add-on therapy in patients with multiple sclerosis spasticity in Austria.

Journal: Brain and behavior

Published: November 07, 2022

Showing 1-12 of 45

Last Updated: 09/26/2026